DV125 (Divalproex Sodium Delayed-Release 125 mg)

Pill with imprint DV125 is Pink, Elliptical/Oval and has been identified as Divalproex Sodium Delayed-Release 125 mg. It is supplied by Genpharm Inc.

Divalproex sodium is used in the treatment of bipolar disorder; mania; epilepsy; migraine prevention and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 125 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for DV125

Divalproex Sodium Delayed-Release

Imprint: DV125
Strength: 125 mg
Color: Pink
Shape: Elliptical/Oval
Availability: Prescription only
Drug Class: Fatty acid derivative anticonvulsants
Pregnancy Category: D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder, X - Not for use in pregnancy - When treating migraine
CSA Schedule: Not a controlled drug
Labeler / Supplier: Genpharm Inc.
National Drug Code (NDC)